{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:13:55Z","timestamp":1772590435847,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1988,1,1]],"date-time":"1988-01-01T00:00:00Z","timestamp":567993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[1988,1]]},"DOI":"10.1038\/eye.1988.5","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T10:04:41Z","timestamp":1309773881000},"page":"16-23","source":"Crossref","is-referenced-by-count":77,"title":["Clostridium botulinum toxins: nature and preparation for clinical use"],"prefix":"10.1038","volume":"2","author":[{"given":"J","family":"Melling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Hambleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C C","family":"Shone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFeye19885_CR1","first-page":"924","volume":"12","author":"AB Scott","year":"1973","unstructured":"Scott AB, Rosenbaum AL, Collins CC : Pharmacological weakening of extra ocular muscles. Invest Ophthalmol 1973, 12: 924\u20137.","journal-title":"Invest Ophthalmol"},{"key":"BFeye19885_CR2","doi-asserted-by":"crossref","unstructured":"Report of Working Party on Leukaemia in Childhood: Improvement in treatment for children with acute lymphoblastic leukaemia. Lancet 1986, 1: 408.","DOI":"10.1016\/S0140-6736(86)92370-6"},{"key":"BFeye19885_CR3","first-page":"19","volume":"20","author":"B Syuto","year":"1972","unstructured":"Syuto B and Kubo S : Purification and chrystallisation of Clostridium botulinum type C toxin. Jpn J Vet Res 1972. 20: 19\u201330.","journal-title":"Jpn J Vet Res"},{"key":"BFeye19885_CR4","first-page":"207","volume":"168","author":"M Kitamura","year":"1968","unstructured":"Kitamura M, Sakaguchi S, Sakaguchi G : Purification and some properties of Clostridium botulinum type E toxin. Biochem Biophys Acta 1968, 168: 207\u201317.","journal-title":"Biochem Biophys Acta"},{"key":"BFeye19885_CR5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1128\/JB.98.3.1173-1178.1969","volume":"98","author":"M Kitamura","year":"1968","unstructured":"Kitamura M, Sakaguchi S, Sakaguchi G : Significance of 12S toxin of Clostridium botulinum type E. J Bacteriol 1968, 98: 1173\u20138.","journal-title":"J Bacteriol"},{"key":"BFeye19885_CR6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/AEM.28.6.923-928.1974","volume":"28","author":"I Ohishi","year":"1974","unstructured":"Ohishi I and Sakaguchi G : Purification of Clostridium botulinum type F progenitor toxin., Appl Microbiol 1974, 28: 923\u20138.","journal-title":"Appl Microbiol"},{"key":"BFeye19885_CR7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1128\/IAI.17.2.395-401.1977","volume":"17","author":"S Miyazaki","year":"1977","unstructured":"Miyazaki S, Iwasaki M, Sakaguchi G : Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties. Infect Immun 1977, 17: 395\u2013401.","journal-title":"Infect Immun"},{"key":"BFeye19885_CR8","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/IAI.12.6.1262-1270.1975","volume":"12","author":"S Sugii","year":"1975","unstructured":"Sugii S and Sakaguchi G : Molecular construction of Clostridium botulinum type A toxins. Infect Immun 1975, 12: 1262\u201370.","journal-title":"Infect Immun"},{"key":"BFeye19885_CR9","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1128\/IAI.10.4.750-756.1974","volume":"10","author":"S Kazaki","year":"1974","unstructured":"Kazaki S, Sakaguchi S, Sakaguchi G : Purfication and some properties of progenitor toxins of Clostridium botulinum type B. Infect Immun 1974, 10: 750\u20136.","journal-title":"Infect Immun"},{"key":"BFeye19885_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1432-1033.1985.tb09070.x","volume":"151","author":"CC Shone","year":"1985","unstructured":"Shone CC, Hambletpn P, Melling J : Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin binding activity. Eur J Biochem 1985, 151: 75\u201382.","journal-title":"Eur J Biochem"},{"key":"BFeye19885_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1432-1033.1982.tb06464.x","volume":"122","author":"CK Tse","year":"1982","unstructured":"Tse CK, Dolly JO, Hambleton P, Wray D, Melling J Preparation and characterisation of homogenous neurotoxin type A Clostridium botulinum. Its inhibitory action on neural release of acetylcholine in the absence and presence of bun- garotoxin. Eur J Biochem 1982, 122: 493\u2013500.","journal-title":"Eur J Biochem"},{"key":"BFeye19885_CR12","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1016\/S0021-9258(18)94342-5","volume":"244","author":"WH Beers","year":"1969","unstructured":"Beers WH and Reich E : Isolation and characterisation of Clostridium botulinum type B toxin. J Biol Chem 1969, 244: 4473\u20139.","journal-title":"J Biol Chem"},{"key":"BFeye19885_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0041-0101(77)90019-8","volume":"15","author":"BR DasGupta","year":"1977","unstructured":"DasGupta BR and Sugiyama H : Comparative sizes of botulinum type A and B neurotoxins. Toxicon 1977, 15: 357\u201363.","journal-title":"Toxicon"},{"key":"BFeye19885_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1432-1033.1986.tb09413.x","volume":"154","author":"GM Evans","year":"1986","unstructured":"Evans GM, Williams RS, Shone CC, Hambleton P, Melling J, Dolly JO : Botulinum type B. Its purification, radioidination and interaction with rat-brain synaptosomal membranes. Eur J Biochem 1986, 154: 409\u201316.","journal-title":"Eur J Biochem"},{"key":"BFeye19885_CR15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/AEM.33.2.400-405.1977","volume":"33","author":"B Syuto","year":"1977","unstructured":"Syuto B and Kubo S : Isolation and molecular size of Clostridium botulinum type C toxin. Appl Environ Microbiol 1977, 33: 400\u20135.","journal-title":"Appl Environ Microbiol"},{"key":"BFeye19885_CR16","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1016\/S0021-9258(19)69513-X","volume":"256","author":"B Syuto","year":"1981","unstructured":"Syuto B and Kubo S : Separation and characterisation of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution. J Biol Chem 1981, 256: 3712\u201317.","journal-title":"J Biol Chem"},{"key":"BFeye19885_CR17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/IAI.48.2.312-317.1985","volume":"48","author":"J Terajima","year":"1985","unstructured":"Terajima J, Syuto B, Ochanda JO, Kubo S : Purification and characterisation of neurotoxin produced by Clostridium botulinum Type C 6813. Infect Immun 1985, 48: 312\u201317.","journal-title":"Infect Immun"},{"key":"BFeye19885_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1432-1033.1984.tb08312.x","volume":"142","author":"S Murayama","year":"1984","unstructured":"Murayama S, Syoto B, Oguma K, Iida H, Kubo S : Comparison of Clostridium botulinum toxin types D and C1 in molecular property, antigenicity and binding ability to rat-brain synapto- somes. Eur J Biochem 1984, 142: 487\u201392.","journal-title":"Eur J Biochem"},{"key":"BFeye19885_CR19","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AEM.29.5.598-603.1975","volume":"29","author":"KH Yang","year":"1975","unstructured":"Yang KH and Sugiyama H : Purificaiton and properties of Clostridium botulinum type F toxin. Appl Microbiol 1975, 29: 598\u2013603.","journal-title":"Appl Microbiol"},{"key":"BFeye19885_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0041-0101(84)90085-0","volume":"22","author":"BR DasGupta","year":"1984","unstructured":"DasGupta BR and Sathyamoorthy V : Purification and amino acid composition of type A botulinum neurotoxin. Toxicon 1984, 22: 415\u201324.","journal-title":"Toxicon"},{"key":"BFeye19885_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/0041-0101(83)90131-9","volume":"21","author":"BR DasGupta","year":"1983","unstructured":"DasGupta BR and Rasmussen S : Purification and amino acid composition of type E botulinum neurotoxin. Toxicon 1983, 21: 535\u201345.","journal-title":"Toxicon"},{"key":"BFeye19885_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/0041-0101(83)90136-8","volume":"21","author":"BR DasGupta","year":"1983","unstructured":"DasGupta BR and Rasmussen S : Amino acid composition of Clostridium botulinum type F neurotoxin. Toxicon 1983, 21: 566\u20139.","journal-title":"Toxicon"},{"key":"BFeye19885_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.7883\/yoken1952.34.61","volume":"34","author":"S Kozaki","year":"1981","unstructured":"Kozaki S, Togashi S, Sakaguchi G : Separation of Clostridium botulinum type A derivative toxin into two fragments. Jap J Med Sci Biol 1981, 34: 61\u20138.","journal-title":"Jap J Med Sci Biol"},{"key":"BFeye19885_CR24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/IAI.18.3.761-766.1977","volume":"18","author":"S Kozaki","year":"1977","unstructured":"Kozaki S, Miyazaki S, Sakaguchi G : Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin. Infect Immun 1977, 18: 761\u20136.","journal-title":"Infect Immun"},{"key":"BFeye19885_CR25","doi-asserted-by":"crossref","first-page":"10461","DOI":"10.1016\/S0021-9258(19)85105-0","volume":"260","author":"V Sathyamoorthy","year":"1985","unstructured":"Sathyamoorthy V and DasGupta BR : Separation,purification, partial characterisation and comparison of the heavy and light chains of botulinum neurotoxin types A, B and E. J Biol Chem 1985, 260: 10461\u20136.","journal-title":"J Biol Chem"},{"key":"BFeye19885_CR26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1128\/IAI.16.1.107-109.1977","volume":"16","author":"I Ohishi","year":"1977","unstructured":"Ohishi I, Sugii S, Sakaguchi G : Oral toxicities of Clostridium botulinum toxins in response to molecular size. Infect Immun 1977, 16: 107\u20139.","journal-title":"Infect Immun"},{"key":"BFeye19885_CR27","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/IAI.16.3.910-914.1977","volume":"16","author":"S Sugii","year":"1977","unstructured":"Sugii S, Ohishi I, Sakaguchi G : Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes. Infect Immun 1977, 16: 910\u201314.","journal-title":"Infect Immun"},{"key":"BFeye19885_CR28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/IAI.17.3.491-496.1977","volume":"17","author":"S Sugii","year":"1977","unstructured":"Sugii S, Ohishi I, Sakaguchi G : Intestinal absorption of botulinum toxins of different molecular sizes in rats. Infect Immun 1977, 17: 491\u20136.","journal-title":"Infect Immun"},{"key":"BFeye19885_CR29","unstructured":"Sakaguchi G, Kozaki S, Ohishi I : Structure and function of botulinum toxins. In Bacterial Protein Toxins. Ed JE Alouf, EJ Fehrenbach, JH Freer, J Jeljiaszewicz. Academic Press, London, 1984, pp 433\u201343."},{"key":"BFeye19885_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1113\/jphysiol.1949.sp004364","volume":"109","author":"AS Burgen","year":"1949","unstructured":"Burgen AS, Dickens VF, Zatman LJ : The action of botulinum toxin on the neuromuscular junction. J Physiol (London) 1949, 109: 10\u201324.","journal-title":"J Physiol (London)"},{"key":"BFeye19885_CR31","doi-asserted-by":"crossref","unstructured":"Simpson LL : Ionic requirements for the neuromuscular blocking action of botulinum toxin: implications with regard to synaptic transmission. Neuropharmacol 1971, 10: 673\u201384.","DOI":"10.1016\/0028-3908(71)90082-7"},{"key":"BFeye19885_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0028-3908(73)90085-3","volume":"12","author":"LL Simpson","year":"1973","unstructured":"Simpson LL : The interaction between divalent cations and botulinum toxin type A in the paralysis of the rat phrenic nerve-hemidiaphragm preparation. Neuropharmacol 1973, 12: 165\u201376.","journal-title":"Neuropharmacol"},{"key":"BFeye19885_CR33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1113\/jphysiol.1960.sp006463","volume":"151","author":"S Thesleff","year":"1960","unstructured":"Thesleff S : Supersensitivity of skeletal muscle produced by botulinum toxin. J Physiol (Lond) 1960 151: 598\u2013607.","journal-title":"J Physiol (Lond)"},{"key":"BFeye19885_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/307457a0","volume":"307","author":"JO Dolly","year":"1984","unstructured":"Dolly JO, Black J, Williams RS, Melling J . Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalisation. Nature 1984, 307: 457\u201360.","journal-title":"Nature"},{"key":"BFeye19885_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0041-0101(82)90183-0","volume":"20","author":"JO Dolly","year":"1982","unstructured":"Dolly JO, Williams RS, Black JD, Tse CK, Hambleton P, Melling J : Localisation of sites for 125-1 labelled botulinum neurotoxin at the murine neuromuscular junction and its binding to rat brain synaptosomes. Toxicon 1982, 20: 141\u2013l8.","journal-title":"Toxicon"},{"key":"BFeye19885_CR36","doi-asserted-by":"crossref","unstructured":"Hirokawa N and Kitamura M : Binding of Clostridium botulinum neurotoxin to the presynaptic membrane in the central nervous system. J Cell Biol 1979, 81: 43\u20139.","DOI":"10.1083\/jcb.81.1.43"},{"key":"BFeye19885_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1432-1033.1983.tb07282.x","volume":"131","author":"RS Williams","year":"1983","unstructured":"Williams RS, Tse CK, Dolly JO, Hambleton P, Melling J : Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to rat brain synaptosomes. Eur J Biochem 1983, 131: 437\u201345.","journal-title":"Eur J Biochem"},{"key":"BFeye19885_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/oxfordjournals.jbchem.a134383","volume":"94","author":"T Agui","year":"1983","unstructured":"Agui T, Syuto B, Oguma K, Iida H and Kubo S : Binding of Clostridium Botulinum type C neurotoxin to rat brain synaptosomes. J Biochem 1983, 94: 521\u20137.","journal-title":"J Biochem"},{"key":"BFeye19885_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/oxfordjournals.jbchem.a135047","volume":"97","author":"T Agui","year":"1985","unstructured":"Agui T, Syuto B, Oguma K, Iida H, Kubo S : The structural relation between the antigenic determinants to monoclonal antibodies and binding sites to rat brain synaptosomes and GTlb gang- lioside in Clostridium botulinum type C neurotoxin. J Biochem 1985, 97: 213\u20138.","journal-title":"J Biochem"},{"key":"BFeye19885_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF00499721","volume":"308","author":"S Kozaki","year":"1979","unstructured":"Kozaki S : Interaction of botulinum type A, B and E derivative toxins, with synaptosomes of rat brain, et al.; Naunyn-Schmeideberg's Arch Pharmacol 1979, 308: 67\u201370.","journal-title":"Naunyn-Schmeideberg's Arch Pharmacol"},{"key":"BFeye19885_CR41","first-page":"252","volume":"79","author":"F Dreyer","year":"1984","unstructured":"Dreyer F, Becker C, Bigalke H, Funk J, Penner R, Rosenberg F, Ziegler M : Action of botulinum A toxin and tetanus toxin on synaptic transmission. J Physiol (Paris) 1984, 79: 252\u2013258.","journal-title":"J Physiol (Paris)"},{"key":"BFeye19885_CR42","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0041-0101(82)90071-X","volume":"20","author":"S Kozaki","year":"1982","unstructured":"Kozaki S and Sakaguchi G : Binding to mouse brain synaptosomes of Clostridium botulinum type E derivative toxin before and after tryptic activation. Toxicon 1982, 20: 841\u20136.","journal-title":"Toxicon"},{"key":"BFeye19885_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1113\/jphysiol.1976.sp011510","volume":"260","author":"SG Cullcandy","year":"1976","unstructured":"Cullcandy SG, Lundh H, Thesleff S : Effects of botulinum toxin on neuromuscular transmission in the rat. J Physiol (London) 1976, 260: 177\u2013203.","journal-title":"J Physiol"},{"key":"BFeye19885_CR44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3565(25)31371-6","volume":"206","author":"LL Simpson","year":"1978","unstructured":"Simpson LL : Pharmacological studies on.the sub-cellular site of action of botulinum toxin type A. J Pharmacol Exp ther 1978, 206: 661\u20139.","journal-title":"A. J Pharmacol Exp ther"},{"key":"BFeye19885_CR45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0006-8993(76)90222-5","volume":"110","author":"H Lundh","year":"1976","unstructured":"Lundh H, Cullcandy SG, Leander S, Thesleff S : Restoration of neurotransmitter release in the botulinum-poisoned skeletal muscle. Brain Res 1976, 110: 194\u20138.","journal-title":"Brain Res"},{"key":"BFeye19885_CR46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0014-2999(77)90176-5","volume":"42","author":"H Lundh","year":"1977","unstructured":"Lundh H and Thesleff S : The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals. Eur J Pharmacol 1977, 42: 411\u201312.","journal-title":"Eur J Pharmacol"},{"key":"BFeye19885_CR47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)06852-8","volume":"33","author":"LL Simpson","year":"1981","unstructured":"Simpson LL : The origin, structure and pharmacological activity of botulinum toxin. Pharmacol Rev 1981, 33: 155\u201388.","journal-title":"Pharmacol Rev"},{"key":"BFeye19885_CR48","doi-asserted-by":"crossref","unstructured":"Hambleton P, Capel B, Bailey N, Heron N, Crooks A, Melling J : Production, purification and toxoiding of Clostridium botulinum type A toxin. In Biomedical Aspects of Botulism (Lewis, GE, Ed), Academic Press 1981, 247\u201360.","DOI":"10.1016\/B978-0-12-447180-1.50024-9"},{"key":"BFeye19885_CR49","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/S0002-9394(14)77954-1","volume":"99","author":"N Shorr","year":"1985","unstructured":"Shorr N, Seiff SR, Kopelman J : The use of botulinum toxin in blepharospasm. Am J Ophthalmol 1985, 99: 542\u20136.","journal-title":"Am J Ophthalmol"},{"key":"BFeye19885_CR50","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S0161-6420(85)33982-9","volume":"92","author":"AB Scott","year":"1985","unstructured":"Scott AB and Kraft SP : Botulinum toxin injection in the management of lateral rectus paresis. Ophthalmology 1985, 92: 676\u201383.","journal-title":"Ophthalmology"},{"key":"BFeye19885_CR51","doi-asserted-by":"crossref","unstructured":"Savino PJ, Sergott RC, Bosley TM, Schatz NJ : Hemifacial spasm treated with botulinum A toxin injection. Arch Ophthalmol. 1985, 103: 1305\u20136.","DOI":"10.1001\/archopht.1985.01050090057031"},{"key":"BFeye19885_CR52","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.35.10.1499","volume":"35","author":"JA Mauriello","year":"1985","unstructured":"Mauriello JA : Blepharospasm, Meige syndrome and hemifacial spasm treated with botulinum toxin. Neurology 1985, 35: 1499\u2013500.","journal-title":"Neurology"},{"key":"BFeye19885_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","volume":"ii","author":"JKC Tsui","year":"1986","unstructured":"Tsui JKC, Eisen A, Stoessl AJ, Calne S, Calne DB : Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 1986. ii: 245\u20137.","journal-title":"Lancet"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye19885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye19885","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye19885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T22:04:23Z","timestamp":1741298663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye19885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1988,1]]}},"alternative-id":["BFeye19885"],"URL":"https:\/\/doi.org\/10.1038\/eye.1988.5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,1]]}}}